PACT: cloning and characterization of a cellular p53 binding protein that interacts with Rb.

Department of Genetics, The Hebrew University of Jerusalem, Israel.
Cellular functions of tumor suppressor proteins can be mediated by protein-protein interactions. Using p53 as a probe to screen an expression library, a cDNA encoding a 250 kDa protein was isolated. Recombinant forms of this protein, designated PACT, bind to wild type p53 while two different mutations abolish this interaction. PACT protein can also interfere with p53 specific DNA binding. PACT contains a serine/arginine (SR) rich region and a C' terminal lysine rich domain. The 250 kDa PACT protein can be precipitated from cell lysates by a method specific for SR proteins. snRNPs can be co-immunoprecipitated from cells with anti-PACT antibodies. These antibodies stain cell nuclei in a speckled pattern reminiscent of the distribution of known splicing factors. Recently, RBQ1, a truncated human homologue of PACT was identified by virtue of Rb binding. We show that RBQ1 is truncated as a result of a possible mutational event. PACT can interact with both cellular Rb and p53.
Mesh Terms:
Alternative Splicing, Animals, Base Sequence, Carrier Proteins, Cloning, Molecular, DNA, Humans, Male, Mice, Molecular Sequence Data, Mutation, RNA-Binding Proteins, Retinoblastoma Protein, Ribonucleoproteins, Small Nuclear, Testis, Tumor Suppressor Protein p53
Oncogene Jan. 16, 1997; 14(2);145-55 [PUBMED:9010216]
Download 4 Interactions For This Publication
Switch View:
  • Interactions (4)